Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Parkinson’s disease.
Rick Gonzalez lays out plan for internal candidate to take over as AbbVie’s CEO
Rick Gonzalez, AbbVie’s founding CEO, is working on his exit after more than a decade at the helm — and it’s going to be an